
Metabolomics Market by Product & Service (Bioinformatics Tools & Services, Metabolomics Instruments), Indication (Cancer, Cardiovascular Disorders, Inborn Errors of Metabolism), Application, End User - Global Forecast 2024-2030
Description
Metabolomics Market by Product & Service (Bioinformatics Tools & Services, Metabolomics Instruments), Indication (Cancer, Cardiovascular Disorders, Inborn Errors of Metabolism), Application, End User - Global Forecast 2024-2030
The Metabolomics Market size was estimated at USD 3.74 billion in 2023 and expected to reach USD 4.28 billion in 2024, at a CAGR 15.06% to reach USD 9.99 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Metabolomics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Metabolomics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Metabolomics Market, highlighting leading vendors and their innovative profiles. These include Afekta Technologies Ltd., Bio-Rad Laboratories, Inc., Biocrates Life Science AG, Bruker Corporation, Danaher Corporation, General Electric Company, Hitachi High-Tech Corporation, Human Metabolome Technologies America Inc., Japan Spectroscopic Company, Kore Technology Limited, LECO Corporation, Merck KGaA, SCION Instruments UK Ltd, Shimadzu Corporation, and Waters Corporation.
Market Segmentation & Coverage
This research report categorizes the Metabolomics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product & Service
Bioinformatics Tools & Services
Bioinformatics Services
Bioinformatics Tools & Databases
Metabolomics Instruments
Detection Tools
Mass Spectrometry
Nuclear Magnetic Resonance Spectroscopy
Surface-Based Mass Analysis
Separation Tools
Capillary Electrophoresis
Gas Chromatography
High-performance Liquid Chromatography
Ultra-performance Liquid Chromatography
Indication
Cancer
Cardiovascular Disorders
Inborn Errors of Metabolism
Metabolic Disorders
Neurological Disorders
Application
Biomarker discovery
Drug discovery
Functional Genomics
Nutrigenomics
Personalized medicine
Toxicology testing
End User
Academic & Research Institutes
Contract Research Organizations
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Metabolomics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Metabolomics Market?
3. What are the technology trends and regulatory frameworks in the Metabolomics Market?
4. What is the market share of the leading vendors in the Metabolomics Market?
5. Which modes and strategic moves are suitable for entering the Metabolomics Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
189 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Metabolomics Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Prevalence of cancer cases and need for advanced therapies
- 5.1.1.2. Ongoing adoption of personalized medicines
- 5.1.1.3. Favorable governmental initiatives associated with metabolomics research
- 5.1.2. Restraints
- 5.1.2.1. Concern regarding the complex data monitoring and data processing
- 5.1.3. Opportunities
- 5.1.3.1. Emergence of novel technologies along with market players for metabolomics
- 5.1.3.2. Rise of single-cell metabolomics
- 5.1.4. Challenges
- 5.1.4.1. Scarcity of skilled professionals in the healthcare sectors worldwide
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Metabolomics Market, by Product & Service
- 6.1. Introduction
- 6.2. Bioinformatics Tools & Services
- 6.3.1. Bioinformatics Services
- 6.3.2. Bioinformatics Tools & Databases
- 6.3. Metabolomics Instruments
- 6.4.1. Detection Tools
- 6.4.2.1. Mass Spectrometry
- 6.4.2.2. Nuclear Magnetic Resonance Spectroscopy
- 6.4.2.3. Surface-Based Mass Analysis
- 6.4.2. Separation Tools
- 6.4.3.1. Capillary Electrophoresis
- 6.4.3.2. Gas Chromatography
- 6.4.3.3. High-performance Liquid Chromatography
- 6.4.3.4. Ultra-performance Liquid Chromatography
- 7. Metabolomics Market, by Indication
- 7.1. Introduction
- 7.2. Cancer
- 7.3. Cardiovascular Disorders
- 7.4. Inborn Errors of Metabolism
- 7.5. Metabolic Disorders
- 7.6. Neurological Disorders
- 8. Metabolomics Market, by Application
- 8.1. Introduction
- 8.2. Biomarker discovery
- 8.3. Drug discovery
- 8.4. Functional Genomics
- 8.5. Nutrigenomics
- 8.6. Personalized medicine
- 8.7. Toxicology testing
- 9. Metabolomics Market, by End User
- 9.1. Introduction
- 9.2. Academic & Research Institutes
- 9.3. Contract Research Organizations
- 9.4. Pharmaceutical & Biotechnology Companies
- 10. Americas Metabolomics Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Metabolomics Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Metabolomics Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Afekta Technologies Ltd.
- 14.1.2. Bio-Rad Laboratories, Inc.
- 14.1.3. Biocrates Life Science AG
- 14.1.4. Bruker Corporation
- 14.1.5. Danaher Corporation
- 14.1.6. General Electric Company
- 14.1.7. Hitachi High-Tech Corporation
- 14.1.8. Human Metabolome Technologies America Inc.
- 14.1.9. Japan Spectroscopic Company
- 14.1.10. Kore Technology Limited
- 14.1.11. LECO Corporation
- 14.1.12. Merck KGaA
- 14.1.13. SCION Instruments UK Ltd
- 14.1.14. Shimadzu Corporation
- 14.1.15. Waters Corporation
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. METABOLOMICS MARKET RESEARCH PROCESS
- FIGURE 2. METABOLOMICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. METABOLOMICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. METABOLOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. METABOLOMICS MARKET DYNAMICS
- FIGURE 7. METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
- FIGURE 8. METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. METABOLOMICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
- FIGURE 10. METABOLOMICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. METABOLOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 12. METABOLOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. METABOLOMICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 14. METABOLOMICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. METABOLOMICS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. METABOLOMICS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.